A Phase 3 Study of VSA001 in Chinese Adults With Familial Chylomicronemia Syndrome

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a randomized, double-blinded, placebo controlled, two periods phase 3 clinical study. The primary objective of the study is to evaluate the efficacy and safety of VSA001 injection in Chinese adults with familial chylomicronemia syndrome (FCS). A total of approximately 30 participants will be enrolled in the study.
Epistemonikos ID: 86b9946487675c6d08e5f5236ce3256fc9f850f3
First added on: Feb 19, 2024